Current Practice of Autologous Hematopoietic Progenitor Cell Mobilization in Adult Patients with Multiple Myeloma And Lymphoma: The Results of A Survey From Turkish Hematology Research And Education Group (Threg)
Tarih
2017Yazar
Tekgunduz, Emre
Demirkan, Fatih
Vural, Filiz
Goker, Hakan
Ozdogu, Hakan
Kiki, Ilhami
Aydogdu, Ismet
Kaynar, Leylagul
Erkurt, Mehmet Ali
Cagirgan, Seckin
Besisik, Sevgi
Dagdas, Simten
Koca, Ebru
Kadikoylu, Gurhan
Gunduz, Eren
Yilmaz, Mehmet
Bekoz, Huseyin
Ural, Ali Ugur
Basturk, Abdulkadir
Arat, Mutlu
Albayrak, Murat
Ozturk, Erman
Akyol, Alev
Bolaman, Ali Zahit
Nevruz, Oral
Ozkan, Hasan Atilla
Ozgur, Gokhan
Altuntas, Fevzi
Üst veri
Tüm öğe kaydını gösterÖzet
Autologous hematopoietic cell transplantation (AHCT) is an established treatment option for adult patients presenting with multiple myeloma (MM), Hodgkin lymphoma (HL) and various subtypes of non-Hodgkin lymphoma (NHL) in upfront and/or relapsed/refractory disease settings. Although there are recently published consensus guidelines addressing critical issues regarding autologous hematopoietic progenitor cell mobilization (HPCM), mobilization strategies of transplant centers show high variability in terms of routine practice. In order to understand the current institutional policies regarding HPCM in Turkey and to obtain the required basic data for preparation of a national positional statement on this issue, Turkish Hematology Research and Education Group (ThREG) conducted a web-based HPCM survey. The survey was designed to include multiple-choice questions regarding institutional practice of HPCM in adults presenting MM, HL, and NHL. The representatives of 27 adult HCT centers participated to the study. Here we report the results of this survey shedding light on the real world experience in Turkey in terms of autologous HPCM mobilization strategies in patients presenting with MM and lymphoma. (C) 2017 Elsevier Ltd. All rights reserved.